Introduction {#s1}
============

Alzheimer's disease (AD) is an age-associated neurodegenerative disorder characterized by progressive decline in cognitive function, which typically begins with deterioration in memory [@pone.0094961-Hashimoto1]. The number of people with dementia worldwide in 2010 is estimated at 35.6 million and is projected to nearly double every 20 years to 65.7 million in 2030 and 115.4 million in 2050. AD is the most common form of dementia and possibly contributes to 60--70% of cases [@pone.0094961-World1]. In the US alone, AD is related with an estimated health-care cost of US\$172 billion per year [@pone.0094961-Pubmed1]. The overwhelming number of AD patients, combined with the staggering economic burden, makes AD a public health problem.

The key pathological changes that observed in AD brain tissue are the accumulation of neuritic extracellular amyloid plaques and intracellular neurofibrillary tangles [@pone.0094961-Reitz1]. However, the neuropathological etiology of AD remains unclear, but are probably related with the combined interaction between gene variants and environmental factors [@pone.0094961-Pubmed2]. There have been many genetic polymorphisms reported to be associated with AD, such as amyloid precursor protein *(APP)*, presenilin-1(*PSEN1*), presenilin-2(*PSEN2*) [@pone.0094961-Campion1], apolipoprotein E (*APOE*) [@pone.0094961-Saunders1], [@pone.0094961-Maezawa1] and sortilin-related receptor 1 (*SORL1*) [@pone.0094961-Rogaeva1]. However, as a complex disorder, the genes mentioned-above can not explain the overall genetic susceptibility and it is supposed that some other genes may participate in the development of AD.

Brain-derived neurotrophic factor (BDNF), as a member of the neurotrophic family, plays an important role in the growth, development, differentiation and regeneration of various types of neurons in the central nervous system [@pone.0094961-Fahnestock1]. Autopsy studies found reduced mRNA expression of BDNF in the hippocampus of patients with AD [@pone.0094961-Connor1], which implicates the possible participation of BDNF in the pathogenesis of AD. There have been many polymorphisms studied in *BDNF* gene, such as rs11030104, rs16917204, rs7103411, rs6265 and rs2030324. However, only the last two polymorphisms have been widely studied, with no linkage disequilibrium (LD) between them. What's more, these results are inconsistent and individual studies have relatively small power to confirm this association. For example, the G allele of rs6265 confers risk effect for AD in subjects of Japanese (OR = 1.23, 95% CI = 1.02--1.47) [@pone.0094961-Matsushita1], but no significant association was found in Italians [@pone.0094961-Boiocchi1]. Therefore, we performed a meta-analysis to identify the association of the two polymorphisms in *BDNF* and AD susceptibility.

Materials and Methods {#s2}
=====================

Search Strategy {#s2a}
---------------

A literature search was performed for available articles that were published in English or Chinese (up to November 2013) from the following databases: (1) Pubmed; (2) Web of Science; (3) China National Knowledge Infrastructure (CNKI); (4) Wanfang Med Online; (5) China Biology Medical literature database (CBM). The search used the following keywords: "Alzheimer's disease" or "AD" and "brain-derived neurotrophic factor" or "*BDNF*" and "polymorphism" or "mutation" or "variant". We also reviewed the references of included articles to identify additional articles not captured by our database searches.

Inclusion Criteria {#s2b}
------------------

Two investigators reviewed all relevant studies independently to determine whether an individual study was eligible for inclusion. If the two investigators disagreed about the eligibility of a study, a senior researcher was invited to the discussion. The inclusion criteria were as follows: (1) case-control or cohort study published as an original study to evaluate the association between rs6265 and rs2030324 polymorphisms in *BDNF* gene and AD susceptibility; (2) AD were diagnosed according to NINCDS--ADRDA criteria, DSM-IV criteria or CERAD criteria; (3) genotype frequencies were reported in the articles or could be calculated or ORs and 95% CIs can be obtained; (4) the genotype frequencies of controls are consistent with Hardy-Weinberg equilibrium (HWE); (5) if one study from the same population had been published more than once, we choose the most recent or complete one; (6) English or Chinese language articles were included.

Data Extraction {#s2c}
---------------

Two investigators extracted the data independently and reached a consensus on all items. Information extracted from each study was as follows: first author, publication year, country, ethnicity of studied population, diagnostic criteria for cases, sample size, genotype distributions, mean age and the percentage of male.

Statistical Analysis {#s2d}
--------------------

The chi-square (χ^2^) analysis was used to test deviation from Hardy-Weinberg equilibrium (HWE) for the rs6265 and rs2030324 genotype distribution of *BDNF* gene in control groups, and P\<0.05 was considered as departure from HWE. Pooled measure was used as the inverse variance weighted mean of the logarithm of odds ratio (OR) with 95% confidence intervals (CI) to evaluate the strength of the association of rs6265 and rs2030324 in *BDNF* gene with risk of AD. We conducted analysis for each polymorphism considering dominant (AA+GA vs. GG for rs6265, TT+CT vs. CC for rs2030324), recessive (AA vs. GA+GG for rs6265, TT vs. CT+CC for rs2030324) and codominant (A vs. G for rs6265, T vs. C for rs2030324) models, respectively. I^2^ of Higgins and Thompson was used to describe heterogeneity among studies [@pone.0094961-Higgins1]. The random- effects model (REM) was adopted if significant heterogeneity (I^2^\>50%) was found; otherwise, the fixed-effects model (FEM) was adopted, and Mantel-Haenszel was used to assess the fixed effects. For rs6265 and rs2030324, meta-regression with restricted maximum likelihood estimation was performed to explore the potentially important covariates that might exert substantial impacts on between-study heterogeneity. Specific genetic variants causally associated with common diseases would have small effects (risk ratios mostly \<2.0) [@pone.0094961-Ioannidis1], [@pone.0094961-Khoury1]. Therefore, for sensitive analysis, we excluded the studies with OR\>3.0 or OR\<0.3 for both of the two polymorphisms (rs6265 and rs2030324) to control the impact of outlier values resulting from low cell counts within each single study on the pooled effect. Moreover, the 'leave one out' sensitive analysis was performed using I^2^\>50% as the criteria to evaluate the key studies with substantial impact on between-study heterogeneity [@pone.0094961-KangasKontio1]. When heterogeneity was observed, subgroup analysis was also carried out. Publication bias was evaluated by Harbord's test. An influence analysis was performed to describe how robust the pooled estimator is to removal of individual studies. If the point estimate of its omitted analysis lies outside the 95% CI of the combined analysis, the individual study is suspected of excessive influence [@pone.0094961-Tobias1]. All the statistical analyses were conducted using the STATA version 10 (Stata Corporation, College Station, TX, USA). Two-tailed P≤0.05 was considered as statistically significant.

Results {#s3}
=======

Literature Search and Study Characteristics {#s3a}
-------------------------------------------

The search strategy identified 309 articles from English databases (177 articles from Web of Science, 132 articles from Pubmed), 176 articles from Chinese databases (161 articles from China National Knowledge Infrastructure, 9 articles from Wanfang Med Online, 6 articles from China Biology Medical literature database). 64 articles were reviewed in full-text. Furthermore, we excluded 30 articles according to the inclusion criteria, and obtained 1 additional article through references review. Finally, 35 articles were included in this meta-analysis. [Figure 1](#pone-0094961-g001){ref-type="fig"} showed the flow diagram of literature search.

![Flow diagram of literature search.](pone.0094961.g001){#pone-0094961-g001}

For rs6265, data from 29 published articles [@pone.0094961-Matsushita1], [@pone.0094961-Boiocchi1], [@pone.0094961-Sonali1]--[@pone.0094961-Ventriglia1] with 32 studies were used including 7548 cases and 7334 controls. For rs2030324, 22 articles[@pone.0094961-Matsushita1], [@pone.0094961-Boiocchi1], [@pone.0094961-Fukumoto1], [@pone.0094961-Qian1], [@pone.0094961-Cozza1], [@pone.0094961-Huang1], [@pone.0094961-Zhang1]--[@pone.0094961-Desai1], [@pone.0094961-Vepsalainen1]--[@pone.0094961-Bodner1], [@pone.0094961-Bagnoli1], [@pone.0094961-Cousin1]--[@pone.0094961-Kunugi1] with 23 studies including 5796 cases and 5706 controls were used. The ethnicity of the studies included Caucasian, Asian, African and others. All articles were case-control studies. The detailed characteristics of the two polymorphisms are showed in [Table 1](#pone-0094961-t001){ref-type="table"}, [Table 2](#pone-0094961-t002){ref-type="table"}, [Table 3](#pone-0094961-t003){ref-type="table"} and Table S1 in [File S1](#pone.0094961.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0094961.t001

###### Main characteristics of BDNF gene rs6265 polymorphism genotype distributions in studies included in this meta-analysis.

![](pone.0094961.t001){#pone-0094961-t001-1}

  Author                                                                        Year   Country    Ethnicity   Diagnostic criteria   Mean age (case/control)   Number (case/control)   Genotypes GG/GA/AA   Allele frequency G/A   P for HWE             
  ---------------------------------------------------------------------------- ------ ---------- ----------- --------------------- ------------------------- ----------------------- -------------------- ---------------------- ----------- ---------- ------
  Boiocchi et al. [@pone.0094961-Boiocchi1]                                     2013    Italy     Caucasian      NINCDS-ADRDA                75/57                   191/408              113/63/15             231/150/27         289/93     612/204    0.69
  Sonali et al. [@pone.0094961-Sonali1]                                         2013    India       Asian           DSM-IV                 64.9/64.9                  57/63                3/32/22               12/23/28           38/76      47/79     0.10
  Ou et al. [@pone.0094961-Ou1]                                                 2012    China       Asian        NINCDS-ADRDA             78.66/78.71                 58/52                16/28/14              14/25/13           60/56      53/51     0.79
  Borroni et al. [@pone.0094961-Borroni1]                                       2012    Italy     Caucasian         DSM-IV                 77.6/64.2                 234/162              128/87/19              89/63/10          343/125     241/83    1.00
  Fukumoto et al. [@pone.0094961-Fukumoto1]                                     2010    Japan       Asian        NINCDS-ADRDA              73.5/67.1                 657/525             218/319/120            197/249/79         755/559    643/407    1.00
  Qi et al. [@pone.0094961-Qi1]                                                 2009    China       Asian        NINCDS--ADRDA             86.8/86.3                  80/86                27/32/21              27/48/11           86/74      102/70    0.18
  Feher et al. [@pone.0094961-Feher1]                                           2009   Hungary    Caucasian      NINCDS--ADRDA             73.7/71.7                 160/164               94/56/10              52/79/33          244/76     183/145    0.75
  Qian et al. [@pone.0094961-Qian1]                                             2008    China       Asian        NINCDS--ADRDA            72.89/72.77                105/105               28/52/25              25/56/24          108/102    106/104    0.56
  Cozza et al. [@pone.0094961-Cozza1]                                           2008    Italy     Caucasian         DSM-IV                  Na/64.2                  251/97               152/84/15              60/33/4           388/114     153/41    1.00
  Yu et al. [@pone.0094961-Yu1]                                                 2008    China       Asian        NINCDS-ADRDA             73.25/68.82                 99/99                31/41/27              28/51/20          103/95      107/91    0.84
  He et al. [@pone.0094961-He1]                                                 2007    China       Asian        NINCDS-ADRDA              75.7/70.1                 513/575             155/245/113           165/285/125         555/471    615/535    0.93
  Huang et al. [@pone.0094961-Huang1]                                           2007   America    Caucasian      NINCDS-ADRDA                Na/72                   220/128               150/66/4              98/25/5           366/74      221/35    0.06
  Forero et al. [@pone.0094961-Forero1]                                         2006   Colombia     Mixed        NINCDS--ADRDA             73.3/71.8                 101/168               72/27/2               131/34/3          171/31      296/40    0.71
  Zhang et al. [@pone.0094961-Zhang1]                                           2006   America    Caucasian      NINCDS-ADRDA              69.1/37.5                 295/250              178/108/9             166/74/10          464/126     406/94    0.68
  Tsai et al. [@pone.0094961-Tsai1]                                             2006    China       Asian        NINCDS--ADRDA             74.9/73.7                 175/189               43/92/40              64/95/30          178/172    223/155    0.66
  Akatsu et al. [@pone.0094961-Akatsu1]                                         2006    Japan       Asian            CERAD                 83.5/81.6                 95/108                25/58/12              35/53/20          108/82      123/93    1.00
  Saarela et al. [@pone.0094961-SaarelaM1] [\*](#nt101){ref-type="table-fn"}    2006   Finland    Caucasian      NINCDS-ADRDA                Na/79                   97/101                62/32/3               81/17/3           156/38      179/23    0.11
  Lee et al. [@pone.0094961-Lee1]                                               2005   America     Unknown       NINCDS--ADRDA              80.4/75                   95/70                45/47/3               32/30/8           137/53      94/46     0.79
  Desai et al. [@pone.0094961-Desai1] [\*](#nt101){ref-type="table-fn"}         2005   America    Caucasian      NINCDS--ADRDA              Na/75.7                  995/671              662/299/34            456/197/18        1623/367    1109/233   0.69
  Desai et al. [@pone.0094961-Desai1] [\*](#nt101){ref-type="table-fn"}         2005   America     African       NINCDS--ADRDA             Na/70.49                   64/45                 59/5/0                42/3/0            123/5       87/3     1.00
  Bian et al. [@pone.0094961-Bian1]                                             2005    China       Asian        NINCDS--ADRDA              Na/70.2                  203/239              49/113/41             73/115/51          211/195    261/217    0.70
  Vepsalainen et al. [@pone.0094961-Vepsalainen1]                               2005   Finland    Caucasian      NINCDS--ADRDA               Na/70                   375/460               280/87/8             342/109/9          647/103    793/127    0.85
  Matsushita et al. [@pone.0094961-Matsushita1]                                 2005    Japan       Asian        NINCDS--ADRDA             76.1/75.2                 487/471              171/247/69            150/223/98         589/385    523/419    0.41
  Nishimura et al. [@pone.0094961-Nishimura1]                                   2005    Japan       Asian        NINCDS-ADRDA              77.4/68.4                 172/275               61/85/26             88/140/47          207/137    316/234    0.54
  Bodner et al. [@pone.0094961-Bodner1]                                         2005   America    Caucasian      NINCDS-ADRDA                83/81                   256/194               163/85/8              126/62/6          411/101     314/74    0.82
  Li et al. [@pone.0094961-Li1] [\*](#nt101){ref-type="table-fn"}               2005   England    Caucasian      NINCDS-ADRDA                Na/Na                   359/396              239/105/15            269/114/13         583/135    652/140    0.86
  Li et al. [@pone.0094961-Li1] [\*](#nt101){ref-type="table-fn"}               2005   America    Caucasian      NINCDS-ADRDA                Na/Na                   188/361               109/73/6             235/110/16         291/85     580/142    0.51
  Li et al. [@pone.0094961-Li1] [\*](#nt101){ref-type="table-fn"}               2005   America    Caucasian      NINCDS-ADRDA                Na/Na                   388/349              251/126/11            237/105/7          628/148    579/119    0.34
  Nacmias et al. [@pone.0094961-Nacmias1]                                       2004    Italy     Caucasian      NINCDS--ADRDA             72.2/72.9                  83/97                48/29/6               55/38/4           125/41      148/46    0.58
  Bagnoli et al. [@pone.0094961-Bagnoli1]                                       2004    Italy     Caucasian      NINCDS-ADRDA              71.1/72.9                 128/97                62/60/6               55/38/4           184/72      148/46    0.58
  Combarros et al. [@pone.0094961-Combarros1]                                   2004    Spain     Caucasian      NINCDS-ADRDA              75.3/79.9                 237/218              149/78/10              143/67/8          376/98      353/83    1.00
  Ventriglia et al. [@pone.0094961-Ventriglia1]                                 2002    Italy     Caucasian      NINCDS-ADRDA                72/Na                   130/111               85/33/12              54/48/9           203/57      156/66    0.82

The cases of these studies are late-onset Alzheimer's disease (LOAD); Abbreviations: Na, not available; HWE, Hardy-Weinberg equilibrium. NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition); CERAD, Consortium to Establish a Registry for Alzheimer's disease.

10.1371/journal.pone.0094961.t002

###### Genotype and allele distribution for rs6265 polymorphism in female and other subgroups.

![](pone.0094961.t002){#pone-0094961-t002-2}

  Author                                                                        Year   Country    Ethnicity   Mean age (case/control)   Genotypes GG/GA/AA   Allele frequency (G/A)   Genotypes GG/GA/AA   Genotypes GG/GA/AA   Allele frequency (G/A)                                                 
  ---------------------------------------------------------------------------- ------ ---------- ----------- ------------------------- -------------------- ------------------------ -------------------- -------------------- ------------------------ --------- ------------ ------------ ---------- ----------
  Boiocchi et al. [@pone.0094961-Boiocchi1]                                     2013    Italy     Caucasian            75/57                 69/42/9               130/81/14                180/60              341/109                 109/33           271/95        Na           Na          Na         Na
  Ou et al. [@pone.0094961-Ou1]                                                 2012    China       Asian           78.66/78.71               7/6/5                  4/7/5                  20/16                15/17                 219/171           251/235       Na           Na          Na         Na
  Fukumoto et al. [@pone.0094961-Fukumoto1]                                     2010    Japan       Asian            73.5/67.1              142/205/80             122/143/40              489/365              387/223                 40/40             38/34        Na           Na          Na         Na
  Yu et al [@pone.0094961-Yu1]                                                  2008    China       Asian           73.25/68.82              13/11/13               11/27/11                37/37                49/49                  47/21             40/24        Na           Na          Na         Na
  He et al. [@pone.0094961-He1]                                                 2007    China       Asian            75.7/70.1              92/152/74              97/170/65               336/300              364/300                 34/16             48/24    131/189/93   128/208/94   451/375    464/396
  Forero et al. [@pone.0094961-Forero1]                                         2006   Colombia     Mixed            73.3/71.8               51/20/2                90/23/2                 122/24               203/27                  49/7             93/13        Na           Na          Na         Na
  Tsai et al. [@pone.0094961-Tsai1]                                             2006    China       Asian            74.9/73.7               19/50/15               33/50/18                88/80                116/86                530/128           420/100       Na           Na          Na         Na
  Akatsu et al. [@pone.0094961-Akatsu1]                                         2006    Japan       Asian            83.5/81.6               16/36/6                30/42/14                68/48                102/70                  35/1             23/1         Na           Na          Na         Na
  Saarela et al. [@pone.0094961-SaarelaM1] [\*](#nt102){ref-type="table-fn"}    2006   Finland    Caucasian            Na/79                 45/21/2                46/10/0                 111/25               102/10                 104/86           142/126    62/32/3      81/17/3      156/38     179/23
  Lee et al. [@pone.0094961-Lee1]                                               2005   America     Unknown            80.4/75                31/28/2                20/14/4                 90/32                54/22                 185/109           161/139       Na           Na          Na         Na
  Desai et al. [@pone.0094961-Desai1] [\*](#nt102){ref-type="table-fn"}         2005   America    Caucasian           Na/75.7               449/201/19             287/115/9               1099/239             689/133                 90/92            107/69    662/299/34   456/197/18   1623/367   1109/233
  Desai et al. [@pone.0094961-Desai1] [\*](#nt102){ref-type="table-fn"}         2005   America     African           Na/70.49                 42/4/0                 31/2/0                  88/4                 64/2                  40/34             21/23      59/5/0       42/3/0      123/5       87/3
  Bian et al. [@pone.0094961-Bian1]                                             2005    China       Asian             Na/70.2                20/67/21               36/47/22               107/109               119/91                 45/13             77/13     34/73/27     58/90/42    141/127    206/174
  Matsushita et al. [@pone.0094961-Matsushita1]                                 2005    Japan       Asian            76.1/75.2              117/170/53             104/154/63              404/276              362/280                 66/58             58/42    137/195/54   150/223/98   469/303    523/419
  Li et al. [@pone.0094961-Li1] [\*](#nt102){ref-type="table-fn"}               2005   England    Caucasian            Na/Na                178/73/14               192/73/5               429/101               457/83                266/194           256/184   239/105/15   269/114/13   583/135    652/140
  Li et al. [@pone.0094961-Li1] [\*](#nt102){ref-type="table-fn"}               2005   America    Caucasian            Na/Na                 51/32/4                150/67/9                134/40               367/85                 115/37            99/27     109/73/6    235/110/16    291/85    580/142
  Li et al. [@pone.0094961-Li1] [\*](#nt102){ref-type="table-fn"}               2005   America    Caucasian            Na/Na                 163/81/4               150/60/5                407/89               360/70                 118/26           140/38    251/126/11   237/105/7    628/148    579/119
  Nacmias et al. [@pone.0094961-Nacmias1]                                       2004    Italy     Caucasian          72.2/72.9               36/19/3                39/22/0                 91/25                100/22                 146/42           201/51        Na           Na          Na         Na
  Combarros et al. [@pone.0094961-Combarros1]                                   2004    Spain     Caucasian          75.3/79.9               107/47/7               105/44/6                261/61               254/56                 221/59           219/49        Na           Na          Na         Na

The cases of these studies are late-onset Alzheimer's disease (LOAD). Abbreviations: Na, not available.

10.1371/journal.pone.0094961.t003

###### Main characteristics of BDNF gene rs2030324 polymorphism genotype and allele distributions in studies included in this meta-analysis.

![](pone.0094961.t003){#pone-0094961-t003-3}

  Author                                                                           Year   Country    Ethnicity   Diagnostic criteria   Mean age (case/control)   Number (case/control)   Genotypes CC/CT/TT   Allele frequency C/T   P for HWE            
  ------------------------------------------------------------------------------- ------ ---------- ----------- --------------------- ------------------------- ----------------------- -------------------- ---------------------- ----------- --------- ------
  Boiocchi et al. [@pone.0094961-Boiocchi1]                                        2013    Italy     Caucasian      NINCDS-ADRDA                75/57                   192/384               55/93/44             103/192/89         203/181    398/370   1.00
  Cousin et al. [@pone.0094961-Cousin1]                                            2011    France    Caucasian      NINCDS-ADRDA               Na/66.2                  425/470               370/54/1              419/50/1          794/56     888/52    1.00
  Fukumoto et al. [@pone.0094961-Fukumoto1]                                        2010    Japan       Asian        NINCDS-ADRDA              73.5/67.1                 657/525               611/45/1              490/34/1          1267/47    1014/36   0.46
  Hou et al. [@pone.0094961-Hou1] [\*](#nt103){ref-type="table-fn"}                2009    China       Asian        NINCDS-ADRDA             79.21/76.07                203/138               172/31/0              117/21/0          375/31     255/21    1.00
  Qian et al. [@pone.0094961-Qian1]                                                2008    China       Asian        NINCDS--ADRDA            72.89/72.77                105/105               104/1/0                96/8/1            209/1     200/10    0.20
  Cozza et al. [@pone.0094961-Cozza1]                                              2008    Italy     Caucasian         DSM-IV                  Na/64.2                  251/97                212/35/4              80/15/2           459/43     175/19    0.22
  Huang et al. [@pone.0094961-Huang1]                                              2007   America    Caucasian      NINCDS-ADRDA                Na/72                   220/128               202/16/2              113/15/0          420/20     241/15    1.00
  Zhang et al. [@pone.0094961-Zhang1]                                              2006   America    Caucasian      NINCDS-ADRDA              69.1/37.5                 295/250               271/22/2              220/30/0          564/26     470/30    1.00
  Tsai et al. [@pone.0094961-Tsai1]                                                2006    China       Asian        NINCDS--ADRDA             74.9/73.7                 175/189               151/24/0              167/20/2          326/24     354/24    0.16
  Akatsu et al. [@pone.0094961-Akatsu1]                                            2006    Japan       Asian            CERAD                 83.5/81.6                 95/108                 89/6/0               101/7/0            184/6      209/7    1.00
  Saarela et al. [@pone.0094961-SaarelaM1] [\*](#nt103){ref-type="table-fn"}       2006   Finland    Caucasian      NINCDS-ADRDA                Na/79                   97/101                 88/9/0               81/19/1            185/9     181/21    1.00
  Lee et al. [@pone.0094961-Lee1]                                                  2005   American   Caucasian      NINCDS--ADRDA              80.4/75                  106/73                102/4/0                66/7/0            208/4      139/7    1.00
  Desai et al. [@pone.0094961-Desai1] [\*](#nt103){ref-type="table-fn"}            2005   American   Caucasian      NINCDS--ADRDA              Na/75.7                  719/523               629/86/4              454/69/0          1344/94    977/69    0.15
  Desai et al. [@pone.0094961-Desai1] [\*](#nt103){ref-type="table-fn"}            2005   American    African       NINCDS--ADRDA             Na/70.49                   58/42                 54/4/0                38/4/0            112/4      80/4     1.00
  Olin et al. [@pone.0094961-Olin1]                                                2005   American   Caucasian           Na                    77.7/66                  212/202               173/36/3              189/13/0          382/42     391/13    1.00
  Vepsalainen et al. [@pone.0094961-Vepsalainen1]                                  2005   Finland    Caucasian      NINCDS--ADRDA               Na/70                   375/460              90/199/86             124/239/97         379/371    487/433   0.40
  Matsushita et al. [@pone.0094961-Matsushita1]                                    2005    Japan       Asian        NINCDS--ADRDA             76.1/75.2                 487/471               457/30/0              438/33/0          944/30     909/33    1.00
  Nishimura et al. [@pone.0094961-Nishimura1]                                      2005    Japan       Asian        NINCDS-ADRDA              77.4/68.4                 172/275               154/18/0              264/11/0          326/18     539/11    1.00
  Bodner et al. [@pone.0094961-Bodner1]                                            2005   American   Caucasian      NINCDS-ADRDA                83/81                   256/194               230/26/0              175/19/0          486/26     369/19    1.00
  Nishimura et al. [@pone.0094961-Nishimura2] [\*](#nt103){ref-type="table-fn"}    2004    Brazil    Caucasian      NINCDS--ADRDA             68.7/72.3                 188/188               175/13/0              170/17/1          363/13     357/19    0.38
  Bagnoli et al. [@pone.0094961-Bagnoli1]                                          2004    Italy     Caucasian      NINCDS-ADRDA              71.1/72.9                 128/97                113/14/1              83/14/0           240/16     180/14    1.00
  Riemenschneider et al. [@pone.0094961-Riemenschneider1]                          2002    German    Caucasian      NINCDS-ADRDA              69.3/65.6                 210/188               185/24/1              175/13/0          394/26     363/13    1.00
  Kunugi et al. [@pone.0094961-Kunugi1]                                            2001    Japan       Asian        NINCDS-ADRDA                74/55                   170/498               150/19/1              477/21/0          319/21     975/21    1.00

The cases of these studies are late-onset Alzheimer's disease (LOAD); Abbreviations: HWE, Hardy-Weinberg equilibrium. NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition); CERAD, Consortium to Establish a Registry for Alzheimer's disease.

Influence Analysis and Publication Bias {#s3b}
---------------------------------------

For both of the two polymorphisms, no individual study has excessive influence on the pooled effect in any of dominant, recessive and codominant models (data not shown). Harbord's test showed no publication bias for both two polymorphisms.

Quantitative Synthesis {#s3c}
----------------------

### Overall analysis for rs6265 and rs2030324 {#s3c1}

For overall analysis, no significant association was found between A allele and risk of AD in codominant (REM: OR = 1.03, 95% CI = 0.95--1.12), dominant (REM: OR = 1.06, 95% CI = 0.95--1.18) and recessive model (FEM: OR = 1.00, 95% CI = 0.89--1.12) for rs6265 polymorphism. No evidence indicated an association between rs2030324 with AD in codominant (REM: OR = 1.06, 95% CI = 0.89--1.26), dominant (REM: OR = 1.05, 95% CI = 0.86--1.27) and recessive (FEM: OR = 1.09, 95% CI = 0.85--1.39) models. The results for overall analysis are showed in [Table 4](#pone-0094961-t004){ref-type="table"}. [Figure 2](#pone-0094961-g002){ref-type="fig"} presented the forest plot of ORs in codominant model (A vs. G) in overall analysis for rs6265.

![Forest plots of relationship between BDNF gene rs6265 polymorphism and AD risk in codominant model (A vs. G) for overall analysis.\
White diamond donates the pooled OR. Black squares indicate the OR in each study, with square sizes inversely proportional to the standard error of the OR. Horizontal lines represent 95% CIs.](pone.0094961.g002){#pone-0094961-g002}

10.1371/journal.pone.0094961.t004

###### The overall pooled measure on the relation of BDNF gene rs6265 and rs2030324 polymorphism with AD.

![](pone.0094961.t004){#pone-0094961-t004-4}

  Loci                      Inherited model                All included articles   After excluding articles with OR\>3.0 or OR\<0.3                                                                                                     
  ----------- ------------------------------------------- ----------------------- -------------------------------------------------- ------------------ ------- ------ ----------- ------------------ ------------------ ------- ------ -----------------------------------------------------------------------------------------------------------------------
  rs6265                      Codominant                         7548/7334                         1.03(0.95--1.12)                   1.03(0.97--1.08)   63.14   50.9   7548/7334          \-                 \-           \-      \-                                                             \-
                               Dominant                          7548/7334                         1.06(0.95--1.18)                   1.05(0.98--1.13)   63.92   51.5   7491/7271   1.05(0.94--1.16)   1.05(0.98--1.12)   59.64   49.7                                                  [@pone.0094961-Sonali1]
               Recessive[a](#nt104){ref-type="table-fn"}         7484/7289                         1.00(0.86--1.17)                   1.00(0.89--1.12)   42.74   29.8   7313/7100   1.04(0.93--1.17)   1.04(0.93--1.17)   28.00    0                                         [@pone.0094961-Feher1], [@pone.0094961-Lee1]
  rs2030324                   Codominant                         5796/5706                         1.06(0.89--1.26)                   1.06(0.96--1.17)   52.13   57.8   5309/4901   0.99(0.88--1.12)   1.01(0.91--1.12)   22.49   15.5                           [@pone.0094961-Qian1], [@pone.0094961-Olin1], [@pone.0094961-Kunugi1]
                               Dominant                          5796/5706                         1.05(0.86--1.27)                   1.06(0.94--1.19)   51.64   57.4   5309/4901   0.98(0.85--1.13)   0.99(0.88--1.12)   24.11   21.2                           [@pone.0094961-Qian1], [@pone.0094961-Olin1], [@pone.0094961-Kunugi1]
               Recessive[b](#nt105){ref-type="table-fn"}         4419/4405                         1.09(0.85--1.39)                   1.09(0.85--1.39)    15      0     2848/2743   1.05(0.82--1.34)   1.05(0.82--1.34)    10      0     [@pone.0094961-Zhang1], [@pone.0094961-Tsai1], [@pone.0094961-Desai1], [@pone.0094961-Olin1], [@pone.0094961-Kunugi1]

One study about African (Desaia et al)for recessive model was not sufficient to calculated pooled OR.

Seven studies (Hou et al. Akatsu et al. Lee et al. Desaia et al. Matsushita et al. Masataka et al. Bodner et al.) for recessive model were not sufficient to calculated pooled OR.

Abbreviations: AD, Alzheimer's disease; FEM, fixed-effects model; REM, random-effects model.

rs6265: Codominant model, A vs. G; Dominant model, AA+GA vs. GG; Recessive model, AA vs. GA+GG.

rs2030324: Codominant model, T vs C; Dominant model, TT+CT vs. CC; Recessive model, TT vs. CT+CC.

Evidence for heterogeneity (I^2^\>50%) was found in codominant and dominant models considering the association of rs6265 and rs2030324 polymorphisms with AD. Univariate meta-regression with the covariates of publication year, ethnicity, diagnostic criteria, form of AD, age (ratio of mean age in case group to that in control group) and gender (ratio of male percent in case group to that in control group) for the above-mentioned polymorphisms showed that no covariates have significant effect on between-study heterogeneity.

Subgroup Analysis for Both Two Polymorphisms {#s3d}
--------------------------------------------

In the stratified analysis by ethnicity, no evidence indicated the association between rs6265 and AD susceptibility both for Caucasians and Asians in codominant (Caucasian: REM: OR = 1.03, 95% CI = 0.90--1.17; Asian: FEM: OR = 1.03, 95% CI = 0.95--1.11), dominant (Caucasian: REM: OR = 1.04, 95% CI = 0.88--1.22; Asian: FEM: OR = 1.05, 95% CI = 0.94--1.18) and recessive (Caucasian: FEM: OR = 1.01, 95% CI = 0.81--1.25; Asian: FEM: OR = 1.01, 95% CI = 0.88--1.15) models. After stratified by gender, a statistical significant association between rs6265 and risk of AD was observed for females in codominant (FEM: OR = 1.13, 95% CI = 1.04--1.23) and dominant model (FEM: OR = 1.17, 95% CI = 1.05--1.31), but not in recessive model (FEM: OR = 1.13, 95% CI = 0.95--1.35). However, no association was detected for males in codominant model (FEM: OR = 0.98, 95% CI = 0.88--1.08), dominant model (OR = 1.01, 95% CI = 0.88--1.16) and recessive model (FEM: OR = 0.91, 95% CI = 0.74--1.12). When stratified by ethnicity in females, for Caucasian females, the A allele was found contributing significantly to the increased risk of AD in codominant model (FEM: OR = 1.18, 95% CI = 1.03--1.34) and dominant model (FEM: OR = 1.18, 95% CI = 1.01--1.37), not in recessive model (FEM: OR = 1.40, 95% CI = 0.94--2.10). With regard to Asian females, no association was detected in codominant model (FEM: OR = 1.09, 95% CI = 0.98--1.22), dominant model (FEM: OR = 1.15, 95% CI = 0.98--1.36) and recessive model (FEM: OR = 1.09, 95% CI = 0.90--1.33). When stratified by gender in LOAD patients, the A allele was observed significantly associated with AD in female LOAD patients in codominant model (FEM: OR = 1.22, 95% CI = 1.05--1.41) and dominant model (FEM: OR = 1.23, 95% CI = 1.03--1.46), but not in recessive model (FEM: OR = 1.47, 95% CI = 0.88--2.44). However, no association was found in male LOAD patients in any of the above-mentioned models. [Figure 3](#pone-0094961-g003){ref-type="fig"} presented the forest plot of ORs in codominant model (A vs. G) in female group for rs6265.

![Forest plots of relationship between BDNF gene rs6265 polymorphism and AD risk in codominant model (A vs. G) for female group.\
White diamond donates the pooled OR. Black squares indicate the OR in each study, with square sizes inversely proportional to the standard error of the OR. Horizontal lines represent 95% CIs.](pone.0094961.g003){#pone-0094961-g003}

For rs2030324, in the subgroup analysis, for Caucasian, no association was found in codominant model (REM: OR = 1.00, 95% CI = 0.82--1.21), dominant model (REM: OR = 0.97, 95% CI = 0.78--1.22) and recessive model (FEM: OR = 1.10, 95% CI = 0.86--1.40). With regard to Asians, there was no association between T allele and AD susceptibility in codominant model (REM: OR = 1.22, 95% CI = 0.80--1.85), dominant model (REM: OR = 1.24, 95% CI = 0.82--1.89) and recessive model (FEM: OR = 0.81, 95% CI = 0.18--3.71). When stratified by gender, there was still no association between rs2030324 and AD both for females and males in codominant model (Female: FEM OR = 0.97, 95% CI = 0.75--1.26; Male: FEM OR = 1.02, 95% CI = 0.74--1.40), dominant model (Female: FEM: OR = 1.02, 95% CI = 0.74--1.40; Male: OR = 0.87, 95% CI = 0.56--1.34). The pooled results are summarized in [Table 5](#pone-0094961-t005){ref-type="table"} and Table S2 and Table S3 in [File S1](#pone.0094961.s001){ref-type="supplementary-material"}.

10.1371/journal.pone.0094961.t005

###### Subgroup analysis on the relation of BDNF gene rs6265 and rs2030324polymorphism with AD in codominant model.

![](pone.0094961.t005){#pone-0094961-t005-5}

  Loci           Data          Type        Inherited model   All included articles   After excluding articles with OR\>3.0 or OR\<0.3                                                                                                           
  ----------- ----------- --------------- ----------------- ----------------------- -------------------------------------------------- ---------------------- -------- ------- ----------- ------------------ ------------------ ------- ------ ------------------------------------------------
  rs6265       Ethnicity     Caucasian       Codominant            4587/4264                         1.03(0.90--1.17)                     1.03(0.95--1.11)      45.2    64.6       \-              \-                 \-                   \-                          \-
                               Asian         Codominant            2701/2787                         1.04(0.94--1.14)                     1.03(0.95--1.11)     15.67    29.8       \-              \-                 \-           \-      \-                          \-
                Gender      **Female**     **Codominant**        **3246/3120**                     **1.13(1.04--1.23)**                 **1.13(1.04--1.23)**   **18**   **0**      \-              \-                 \-           \-      \-                          \-
                               Male          Codominant            1813/1976                         0.98(0.88--1.08)                     0.98(0.88--1.08)       18       0        \-              \-                 \-           \-      \-                          \-
                 Form          EOAD          Codominant             270/665                          0.96(0.78--1.19)                     0.96(0.78--1.19)       2        0        \-              \-                 \-                   \-                          \-
                               LOAD          Codominant            3024/3014                         1.05(0.93--1.18)                     1.03(0.94--1.12)     12.97    38.3       \-              \-                 \-                   \-                          \-
                Female     **Caucasian**   **Codominant**        **1676/1619**                     **1.18(1.03--1.34)**                 **1.18(1.03--1.34)**   **7**    **0**      \-              \-                 \-           \-      \-                          \-
                               Asian         Codominant            1390/1315                         1.10(0.97--1.24)                     1.09(0.98--1.22)      8.37    16.4       \-              \-                 \-           \-      \-                          \-
                 Male        Caucasian       Codominant             836/936                          1.04(0.88--1.23)                     1.04(0.88--1.23)       7        0        \-              \-                 \-           \-      \-                          \-
                               Asian         Codominant             897/943                          0.97(0.80--1.16)                     0.95(0.83--1.08)     12.13    42.3       \-              \-                 \-           \-      \-                          \-
                 LOAD       **Female**     **Codominant**        **1383/1211**                     **1.22(1.05--1.41)**                 **1.22(1.05--1.41)**   **5**    **0**      \-              \-                 \-           \-      \-                          \-
                               Male          Codominant             682/666                          1.07(0.88--1.30)                     1.07(0.88--1.30)       5        0                        \-                 \-           \-      \-                          \-
  rs2030324    Ethnicity     Caucasian       Codominant            3674/3355                         1.00(0.82--1.21)                     1.03(0.92--1.15)     28.63    54.6    3462/3153   0.96(0.84--1.11)   0.99(0.89--1.11)   15.35   21.8               [@pone.0094961-Olin1]
                               Asian         Codominant            2064/2309                         1.22(0.80--1.85)                     1.22(0.98--1.52)     21.41    67.3    1789/1706   1.11(0.85--1.47)   1.10(0.86--1.39)   6.34    21.1   [@pone.0094961-Qian1], [@pone.0094961-Kunugi1]
                 Form          EOAD          Codominant            303/1359                          1.39(0.66--2.90)                     1.55(0.95--2.53)      6.3     52.4       \-              \-                 \-           \-      \-                          \-
                               LOAD          Codominant            2038/2351                         1.21(0.77--1.89)                     1.18(0.97--1.43)      36.2    77.9    1760/1651   0.91(0.74--1.13)   0.91(0.74--1.13)     6      0     [@pone.0094961-Olin1], [@pone.0094961-Kunugi1]
                Gender        Female         Codominant             696/603                          0.97(0.75--1.26)                     0.97(0.75--1.26)       2        0        \-              \-                 \-           \-      \-                          \-
                               Male          Codominant             356/444                          1.02(0.74--1.40)                     1.02(0.74--1.40)       2        0        \-              \-                 \-                   \-                          \-

Abbreviations: FEM, fixed-effects model; REM, random-effects model. EOAD, early-onset Alzheimer's Disease; LOAD, late-onset Alzheimer's Disease.

rs6265: Codominant model, A vs. G; rs2030324: Codominant model, T vs C.

Sensitivity Analysis {#s3e}
--------------------

After excluding articles with OR\>3.0 or OR\<0.3, low heterogeneity (I^2^\<50%) was found in the codominant, dominant and recessive models, and the results for both two polymorphisms are consistent with the ones without sensitive analysis. Furthermore, the "leave one out" analysis was carried out when significant heterogeneity (I^2^\>50%) was observed. After excluded key articles with substantial impact on between-study heterogeneity, the data showed rs6265 confers a risk effect for Caucasians in codominant model (FEM: OR = 1.08, 95% CI = 1.00--1.17, P = 0.042). With respect to rs2030324, the result indicated T allele was associated with EOAD patients in codominant (FEM: OR = 2.02, 95% CI = 1.18--3.47) and dominant model (FEM: OR = 2.01, 95% CI = 1.15--3.52).

Discussion {#s4}
==========

To our knowledge, many case-control studies have been carried out to investigate the role of *BDNF* gene in the development of AD. However, these results remained controversial. 29 articles concerning rs6265 and 22 articles concerning rs2030324 were included in our meta-analysis. With respect to rs2030324, there was no evidence for an association with AD. What's more, the combined evidence suggested that rs6265 was not associated with AD for overall analysis. After stratified by ethnicity in females, our data indicated rs6265 lead to the increased risk of AD in Caucasian females, but not for Asians. When stratified by gender in LOAD patients, the A allele was found contributing significantly to the increased risk of AD in female LOAD patients. The results of our study were not consistent with the previous meta-analysis conducted by Fukumoto et al. [@pone.0094961-Fukumoto1] in 2010 including 16 studies revealing a gender-related association between rs6265 polymorphism and AD susceptibility. The reason might be that the quantitative assessments in our study were based on a larger sample size and we have performed a detailed subgroup analysis.

The Met66-BDNF protein has been shown to be associated with reduced transport of BDNF from the Golgi region to appropriate secretory granules in neurons, compared with the Val66-BDNF protein [@pone.0094961-delToro1]. Moreover, the A allele of rs6265 was related with poorer episodic memory, abnormal hippocampal activation, and lower hippocampal n-acetyl aspartate (NAA) in human subjects [@pone.0094961-Egan1]. Epidemiological studies showed higher incidence and prevalence of AD in women than in men [@pone.0094961-Pubmed1], [@pone.0094961-Pubmed2]. Molecular mechanisms underlying this correlation had been considered as colocalization estrogen receptors with BDNF-synthesizing neurons in the forebrain [@pone.0094961-Miranda1] and induction BDNF expression by estrogen through the estrogen response element [@pone.0094961-Sohrabji1]. In addition, though the two forms of AD (EOAD and LOAD) have different patterns of genetic epidemiology [@pone.0094961-Reitz1], the results of our study revealed no difference between them.

Between-study heterogeneity is common in meta-analysis for genetic association studies [@pone.0094961-MunafoMR1] and it is essential to explore the potential sources of between-study heterogeneity [@pone.0094961-Lau1]. This meta-analysis also showed significant between-study heterogeneity in dominant model and codominant model for both two polymorphisms. An indeterminate number of characteristics that varied among studies could be the sources of between-study heterogeneity, such as publication year, ethnicity, diagnostic criteria, form of AD, age, and gender etc. Therefore, in order to explore the potential sources of between-study heterogeneity for rs6265 and rs2030324, meta-regression was adopted. However, the aforementioned covariates were not important contributors to this disease-effect heterogeneity. Considering that our meta-analysis showed significant heterogeneity, subgroup analyses by ethnicity (Caucasian and Asian), form of AD (EOAD and LOAD) and gender (female and male) etc. were performed to explore the sources of heterogeneity. However, between-study heterogeneity still existed in subgroups, suggesting the presence of other unknown confounders. AD is a complex multi-factorial disease and is related with the combined effects between gene variants and environmental factors. Therefore, other genetic and environment variables, as well as their possible interaction, may be potential contributors to this disease-effect unconformity. We further conducted a sensitivity analysis excluding articles with OR\>3 or OR\<0.3. After sensitivity analysis, low heterogeneity (I^2^\<50%) was found in the codominant, dominant and recessive models, and the results are consistent with the one before heterogeneity analysis for rs6265 and rs2030324, strongly identified the stability of our results. Moreover, no publication bias was found in any of the above-mentioned models for both two polymorphisms.

The major strength of our meta-analysis is that the results were based on the large number of participators, allowing a much greater possibility of reaching definitive conclusions. Additionally, we conducted subgroup analyses to explore the potential sources of heterogeneity, and sensitivity analysis was carried out to ensure the stability of our results. However, our meta-analysis also had some limitations. Firstly, lack of the original data of included articles made it impracticable to excluded potential confounders completely, especially the confounding of age. Secondly, different diagnostic criteria may have possible influence on the diagnosis of AD.

In conclusion, this meta-analysis suggested A allele of rs6265 might increase the risk of AD in Caucasian females and female LOAD patients. In addition, no evidence indicated an association between rs2030324 with AD. Since potential biases and confounders could not be ruled out completely in this study, further studies are needed to confirm these results.
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